Institute for Human Genetics, Newcastle University, Newcastle upon Tyne, UK.
Mitochondrion. 2011 Jul;11(4):620-2. doi: 10.1016/j.mito.2011.03.004. Epub 2011 Mar 21.
Leber's hereditary optic neuropathy (LHON) is a common cause of inherited blindness, primarily due to one of three mitochondrial DNA (mtDNA) mutations. LHON, which has an unexplained variable penetrance and pathology, is characterised by disruption of the mitochondrial respiratory chain ultimately resulting in degeneration of the retinal ganglion cells. Phosphorylation of the tau protein is known to cause neurodegeneration and variation in MAPT has been associated with a range of neurodegenerative disorders. Given the relationship between MAPT variation and altered mitochondrial respiratory chain function, we hypothesised that MAPT variation could contribute to the risk of blindness in LHON mtDNA mutation carriers. We studied MAPT variation in a large, well characterised LHON cohort, but were unable to find an association between MAPT genetic variation and visual failure in LHON mtDNA mutation carriers. Our findings suggest that genetic variation in MAPT is unlikely to make a major contribution to the risk of blindness among LHON mutation carriers.
Leber 遗传性视神经病变(LHON)是一种常见的遗传性失明原因,主要是由于三种线粒体 DNA(mtDNA)突变之一引起。LHON 的发病机制尚不清楚,其具有不可预测的外显率和病理学特征,表现为线粒体呼吸链的破坏,最终导致视网膜神经节细胞的变性。磷酸化的 tau 蛋白已知会导致神经退行性变,并且 MAPT 的变异与一系列神经退行性疾病有关。鉴于 MAPT 变异与改变的线粒体呼吸链功能之间的关系,我们假设 MAPT 变异可能导致 LHON mtDNA 突变携带者失明的风险增加。我们研究了一个大型、特征明确的 LHON 队列中的 MAPT 变异,但未能发现 MAPT 遗传变异与 LHON mtDNA 突变携带者的视力丧失之间存在关联。我们的研究结果表明,MAPT 的遗传变异不太可能对 LHON 突变携带者失明的风险产生重大影响。